F/M Emerald Life Sciences Innovation ETF (LFSC) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

F/M Emerald Life Sciences Innovation ETF (LFSC) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $118.8M, listed on NASDAQ, carrying a beta of 0.92 to the broader market. The F/M Emerald Life Sciences Innovation ETF (LFSC) strategically invests in pioneering life science enterprises. public since 2024-10-21.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for LFSC as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →